Quick Answer
Olema Pharmaceuticals, Inc. reported Net Income of -$162.45 million for fiscal year 2025.
Olema Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$162.45M | -25.5% |
| 2024 | -$129.47M | -34.0% |
| 2023 | -$96.66M | +7.8% |
| 2022 | -$104.79M | -47.4% |
| 2021 | -$71.10M | -221.4% |
| 2020 | -$22.12M | -412.5% |
| 2019 | -$4.32M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$42.22M | -22.2% | +3.6% |
| June 30, 2025 | -$43.78M | -44.1% | -44.1% |
| March 31, 2025 | -$30.39M | +1.9% | +12.1% |
| September 30, 2024 | -$34.55M | -60.7% | -13.7% |
| June 30, 2024 | -$30.38M | -51.2% | +1.9% |
| March 31, 2024 | -$30.97M | -9.5% | -44.0% |
| September 30, 2023 | -$21.50M | +5.4% | -7.0% |
| June 30, 2023 | -$20.09M | +38.8% | +29.0% |
- Olema Pharmaceuticals, Inc. showed a decrease of -25.5% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Olema Pharmaceuticals, Inc.’s net income has declined by 3663.9% (from -$4.32 million to -$162.45 million).
- The most recent figure is from Olema Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: